These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30013173)

  • 21. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
    Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
    J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    Koenig KA; Beall EB; Sakaie KE; Ontaneda D; Stone L; Rao SM; Nakamura K; Jones SE; Lowe MJ
    PLoS One; 2021; 16(6):e0251338. PubMed ID: 34101741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.
    Wottschel V; Chard DT; Enzinger C; Filippi M; Frederiksen JL; Gasperini C; Giorgio A; Rocca MA; Rovira A; De Stefano N; Tintoré M; Alexander DC; Barkhof F; Ciccarelli O;
    Neuroimage Clin; 2019; 24():102011. PubMed ID: 31734524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load.
    He Y; Dagher A; Chen Z; Charil A; Zijdenbos A; Worsley K; Evans A
    Brain; 2009 Dec; 132(Pt 12):3366-79. PubMed ID: 19439423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying and Mapping Connectivity Patterns of Brain Network Hubs in Alzheimer's Disease.
    Dai Z; Yan C; Li K; Wang Z; Wang J; Cao M; Lin Q; Shu N; Xia M; Bi Y; He Y
    Cereb Cortex; 2015 Oct; 25(10):3723-42. PubMed ID: 25331602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.
    Bsteh G; Steiger R; Tuovinen N; Hegen H; Berek K; Wurth S; Auer M; Di Pauli F; Gizewski ER; Deisenhammer F; Berger T; Scherfler C
    Mult Scler; 2020 May; 26(6):706-715. PubMed ID: 30895860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced local segregation of single-subject gray matter networks in adult PTSD.
    Niu R; Lei D; Chen F; Chen Y; Suo X; Li L; Lui S; Huang X; Sweeney JA; Gong Q
    Hum Brain Mapp; 2018 Dec; 39(12):4884-4892. PubMed ID: 30096216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole brain and grey matter volume of Japanese patients with multiple sclerosis.
    Akaishi T; Nakashima I; Mugikura S; Aoki M; Fujihara K
    J Neuroimmunol; 2017 May; 306():68-75. PubMed ID: 28385190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brainstem atrophy in focal epilepsy destabilizes brainstem-brain interactions: Preliminary findings.
    Mueller SG; Bateman LM; Nei M; Goldman AM; Laxer KD
    Neuroimage Clin; 2019; 23():101888. PubMed ID: 31203171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
    Fleischer V; Ciolac D; Gonzalez-Escamilla G; Grothe M; Strauss S; Molina Galindo LS; Radetz A; Salmen A; Lukas C; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kümpfel T; Zettl UK; Knop M; Tumani H; Wiendl H; Gold R; Bittner S; Zipp F; Groppa S; Muthuraman M;
    Ann Neurol; 2022 Feb; 91(2):192-202. PubMed ID: 34967456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.
    Bendfeldt K; Taschler B; Gaetano L; Madoerin P; Kuster P; Mueller-Lenke N; Amann M; Vrenken H; Wottschel V; Barkhof F; Borgwardt S; Klöppel S; Wicklein EM; Kappos L; Edan G; Freedman MS; Montalbán X; Hartung HP; Pohl C; Sandbrink R; Sprenger T; Radue EW; Wuerfel J; Nichols TE
    Brain Imaging Behav; 2019 Oct; 13(5):1361-1374. PubMed ID: 30155789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis.
    Menke RAL; Proudfoot M; Talbot K; Turner MR
    Neuroimage Clin; 2018; 17():953-961. PubMed ID: 29321969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and Functional Connectivity Underlying Gray Matter Covariance: Impact of Developmental Insult.
    Paquola C; Bennett MR; Lagopoulos J
    Brain Connect; 2018 Jun; 8(5):299-310. PubMed ID: 29758994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray matter atrophy patterns within the cerebellum-neostriatum-cortical network in SCA3.
    Guo J; Chen H; Biswal BB; Guo X; Zhang H; Dai L; Zhang Y; Li L; Fan Y; Han S; Liu J; Feng L; Wang Q; Wang J; Liu C; Chen H
    Neurology; 2020 Dec; 95(22):e3036-e3044. PubMed ID: 33024025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.